Visualitza per autor "Carpio Segura, Cecilia Carmen"
Ara mostrant els elements 1-9 d 9
-
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Vieito Villar, Maria; Sepúlveda, Juan Manuel; Galvao De Aquiar, Vladimir; Hernández-Guerrero, T.; Doger, B.; Saavedra Gadea, Omar; Carpio Segura, Cecilia Carmen; Braña Garcia, Irene; Moreno, Victor (Nature Portfolio, 2023-03-13) -
Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation
Hodkinson, Brendan P.; Schaffer, Michael; Brody, Joshua D.; Carpio Segura, Cecilia Carmen; Ben-Yehuda, Dina; Jurczak, Wojciech (Elsevier, 2021-01) -
Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas
Bobillo Varela, Sabela; Crespo Maull, Marta; Escudero Monreal, Laura; Mayor Ferreras, Regina Gabriela; Raheja Makhija, Priyanka; Carpio Segura, Cecilia Carmen; Rubio Pérez, Carlota; Tazón Vega, Bárbara; Palacio García, Carlos; Carabia Juberó, Júlia; Jiménez Bernal, Isabel; Nieto Sáchica, Juan Camilo; Montoro Gómez, Maria Julia; Martínez Ricarte, Francisco Ramón; Castellví Vives, Josep; Simo Perdigo, Marc; Puigdefabregas Horta, Lluis; Abrisqueta, Pau; Bosch Albareda, Francesc; Seoane Suarez, Joan (Ferrata Storti Foundation, 2021-02-20) -
Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study
Rodriguez-Pinilla, Socorro Maria; Sanchez, Joaquin; Perez Seoane, Carlos; López-Jiménez, Javier; Carpio Segura, Cecilia Carmen; Castellví Vives, Josep; Domingo Domenech, Eva; Climent, Fina (Wiley, 2021-01) -
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia
Salamero García, Olga; Willekens, Christophe; Pérez-Simón, José Antonio; Pigneux, Arnaud; Récher, Christian; Carpio Segura, Cecilia Carmen; Bosch Albareda, Francesc; Montesinos, Pau (American Society of Clinical Oncology, 2020-12-20) -
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
Stein, Eytan M.; DeAngelo, Daniel; Chromik, Jörg; Chatterjee, Manik; Bauer, Sebastian; Lin, Chia-Chi; Suárez Rodríguez, Cristina; Carpio Segura, Cecilia Carmen (American Association for Cancer Research, 2023-03-01) -
Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659)
Gordon, Leo; Karmali, Reem; Kaplan, Jason; Popat, Rakesh; Burris, Howard A. III; Ferrari, Silvia; Carpio Segura, Cecilia Carmen; Bosch Albareda, Francesc (Impact Journals, 2023-01-26) -
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL
Perez, Ariel; Iacoboni García-Calvo, Gloria; Penack, Olaf; Jentzsch, Liv; Carpio Segura, Cecilia Carmen; Barba Suñol, Pere; Rejeski, Kai; Bücklein, Veit (BMJ, 2022-05) -
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma
Timmerman, John; Herbaux, Charles; Ribrag, Vincent; Zelenetz, Andrew D.; Houot, Roch; Neelapu, Sattva S.; Carpio Segura, Cecilia Carmen (Wiley, 2020-05)